Immuron Ltd ADR (IMRN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.06M
Last updated: Nov 17, 2026 at 11:04 AM ET
Immuron Ltd ADR (IMRN) Financials: Revenue, Profit and Cash Flow
Immuron Ltd ADR reported revenue of AUD 7.55M for the fiscal year ended Jun 30, 2026, up 3.5% from the year before. That year, net income was AUD -3.75M with a net margin of -49.8%, operating cash flow was AUD -3.00M and free cash flow was AUD -3.00M. The quarter ended Jun 30, 2026 had revenue of AUD 3.58M and net income of AUD -1.95M.
Revenue and Margins
The operating margin was -61.4% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from AUD 1.40M, a compound annual rate of 20.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | 7.55M | +3.5% | 64.5% | -61.4% | -49.8% |
| Jun 2025 | 7.29M | +48.6% | 65.4% | -73.3% | -71.6% |
| Jun 2024 | 4.90M | +171.7% | 68.1% | -118.3% | -141.5% |
| Jun 2023 | 1.80M | +135.8% | 96.4% | -197.8% | -209.8% |
| Jun 2022 | 765.19K | +424.9% | 68.4% | -375.0% | -373.0% |
| Jun 2021 | 145.78K | -94.2% | -456.2% | -5748.5% | -5751.6% |
| Jun 2020 | 2.52M | +5.5% | 72.6% | -115.8% | -115.3% |
| Jun 2019 | 2.39M | +29.5% | 71.5% | -195.0% | -195.0% |
| Jun 2018 | 1.84M | +32.0% | 68.4% | -162.1% | -163.4% |
| Jun 2017 | 1.40M | N/A | 66.0% | -600.9% | -487.3% |
Income Statement
In the fiscal year ended Jun 2026, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.55M | 7.29M | 4.90M | 1.80M | 765.19K | 145.78K | 2.52M | 2.39M | 1.84M | 1.40M |
| Cost of revenue | 2.68M | 2.52M | 1.57M | 64.63K | 241.69K | 810.84K | 688.84K | 680.76K | 582.29K | 474.04K |
| Gross profit | 4.87M | 4.77M | 3.34M | 1.74M | 523.50K | -665.06K | 1.83M | 1.71M | 1.26M | 922.16K |
| Research and development | 1.93M | 3.60M | 5.38M | 2.59M | 657.72K | 1.37M | 1.18M | 1.04M | 2.26M | 4.63M |
| Operating income | -4.63M | -5.34M | -5.80M | -3.57M | -2.87M | -8.38M | -2.92M | -4.66M | -2.99M | -8.39M |
| Net income | -3.75M | -5.22M | -6.94M | -3.79M | -2.85M | -8.38M | -2.90M | -4.66M | -3.01M | -6.80M |
| EBITDA | -4.63M | -5.31M | -5.17M | -3.36M | N/A | -7.92M | -2.87M | N/A | N/A | -8.39M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.58M | 4.11M | 3.29M | 1.65M | 3.99M | 3.99M | 2.00M | 2.55M | 1.27M | 2.36M | 2.36M | 1.18M |
| Gross profit | 2.35M | 2.60M | 2.11M | 1.05M | 2.66M | 2.66M | 1.33M | 1.76M | 878.23K | 1.58M | 1.58M | 790.17K |
| Operating income | -2.46M | -2.26M | -2.84M | -1.40M | -2.54M | -2.54M | -1.27M | -3.78M | -1.89M | -2.02M | -2.02M | -1.01M |
| Net income | -1.95M | -1.88M | -2.76M | -1.36M | -2.49M | -2.49M | -1.24M | -4.86M | -2.43M | -2.07M | -2.07M | -1.04M |
Balance Sheet
As of Jun 2026, cash and equivalents of AUD 9.02M were 69.4% of total assets of 12.99M, against total liabilities of 1.99M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12.99M | 10.09M | 15.55M | 21.99M | 24.86M | 27.05M | 6.20M | 8.56M | 9.24M | 8.29M |
| Current assets | 12.80M | 9.98M | 14.73M | 20.41M | 23.67M | 25.75M | 4.41M | 6.68M | 7.05M | 8.27M |
| Cash and equivalents | 9.02M | 2.83M | 11.66M | 17.16M | 22.11M | 25.05M | 3.25M | 5.12M | 4.73M | 3.99M |
| Total liabilities | 1.99M | 2.06M | 2.84M | 2.37M | 1.68M | 1.16M | 558.25K | 1.21M | 803.34K | 1.71M |
| Short-term debt | N/A | 45.27K | 40.56K | 38.77K | 34.38K | 20.50K | 42.18K | 0 | 0 | 365.86K |
| Shareholder equity | 11.01M | 8.03M | 12.71M | 19.62M | 23.18M | 25.90M | 5.64M | 7.35M | 8.44M | 6.57M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12.99M | 15.12M | 10.09M | 10.13M | 12.17M | 12.17M | 12.17M | 15.55M | 15.55M | 19.88M | 19.88M | 19.88M |
| Total liabilities | 1.99M | 2.06M | 2.06M | 2.06M | 1.83M | 1.83M | 1.83M | 2.84M | 2.84M | 2.36M | 2.36M | 2.36M |
| Cash and equivalents | 9.02M | 9.99M | 2.83M | 2.83M | 7.74M | 7.74M | 7.74M | 11.66M | 11.66M | 15.21M | 15.21M | 15.21M |
| Shareholder equity | 11.01M | 13.06M | 8.03M | 8.07M | 10.34M | 10.34M | 10.34M | 12.71M | 12.71M | 17.53M | 17.53M | 17.53M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Jun 2026.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -3.00M | -6.14M | -5.88M | -2.49M | -3.13M | -3.05M | -3.16M | -1.29M | -3.50M | -7.03M |
| Capital expenditures | 4.65K | 2 | 195 | 7.74K | 10.05K | N/A | 864 | N/A | 6.59K | 5.70K |
| Free cash flow | -3.00M | -6.14M | -5.88M | -2.50M | -3.14M | N/A | -3.17M | N/A | -3.51M | -7.04M |
| Investing cash flow | 2.97M | -2.90M | 327.56K | -2.74M | 11.74K | N/A | -864 | N/A | -5.32K | -5.70K |
| Financing cash flow | 6.35M | 199.75K | 829 | -35.02K | -36.26K | 19.76M | 1.17M | 1.48M | 4.35M | 8.70M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -767.06K | N/A | -2.14M | -1.07M | -3.99M | -3.99M | -2.00M | -1.94M | -1.94M | -1.00M | -1.00M | -1.00M |
| Capital expenditures | N/A | 4.67K | 2 | 0 | 1 | 1 | 195 | 98 | 98 | 1 | 1 | 0 |
| Free cash flow | N/A | N/A | -2.14M | -1.07M | -3.99M | -3.99M | -2.00M | -1.94M | -1.94M | -1.00M | -1.00M | -1.00M |
Frequently Asked Questions About IMRN
What is Immuron Ltd ADR's annual revenue?
Immuron Ltd ADR reported revenue of AUD 7.55M for the fiscal year ended Jun 30, 2026.
How fast is Immuron Ltd ADR's revenue growing?
Revenue was up 3.5% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 61.1%.
Is Immuron Ltd ADR profitable?
No. Immuron Ltd ADR reported net income of AUD -3.75M for the fiscal year ended Jun 30, 2026, with a net margin of -49.8%.
How much free cash flow does IMRN generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of AUD -3.00M minus capital expenditures of AUD 4.65K produced free cash flow of AUD -3.00M.
How much debt does Immuron Ltd ADR have?
The balance sheet dated Jun 30, 2026 reported cash and equivalents of AUD 9.02M.
IMRN pages: Overview, Financials